These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35532737)

  • 21. Disruption of the Opal Stop Codon Attenuates Chikungunya Virus-Induced Arthritis and Pathology.
    Jones JE; Long KM; Whitmore AC; Sanders W; Thurlow LR; Brown JA; Morrison CR; Vincent H; Peck KM; Browning C; Moorman N; Lim JK; Heise MT
    mBio; 2017 Nov; 8(6):. PubMed ID: 29138302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiviral Phosphorodiamidate Morpholino Oligomers are Protective against Chikungunya Virus Infection on Cell-based and Murine Models.
    Lam S; Chen H; Chen CK; Min N; Chu JJ
    Sci Rep; 2015 Jul; 5():12727. PubMed ID: 26224141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stress granule components G3BP1 and G3BP2 play a proviral role early in Chikungunya virus replication.
    Scholte FE; Tas A; Albulescu IC; Žusinaite E; Merits A; Snijder EJ; van Hemert MJ
    J Virol; 2015 Apr; 89(8):4457-69. PubMed ID: 25653451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
    Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
    mBio; 2016 May; 7(3):. PubMed ID: 27222471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of plasmid-based shRNA against the E1 and nsP1 genes effectively silenced Chikungunya virus replication.
    Lam S; Chen KC; Ng MM; Chu JJ
    PLoS One; 2012; 7(10):e46396. PubMed ID: 23056297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and application of a bioluminescent imaging mouse model for Chikungunya virus based on pseudovirus system.
    Wu J; Zhao C; Liu Q; Huang W; Wang Y
    Vaccine; 2017 Nov; 35(47):6387-6394. PubMed ID: 29031692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A high-dose inoculum size results in persistent viral infection and arthritis in mice infected with chikungunya virus.
    Zhang Y; Yan H; Li X; Zhou D; Zhong M; Yang J; Zhao B; Fan X; Fan J; Shu J; Lu M; Jin X; Zhang E; Yan H
    PLoS Negl Trop Dis; 2022 Jan; 16(1):e0010149. PubMed ID: 35100271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chikungunya triggers an autophagic process which promotes viral replication.
    Krejbich-Trotot P; Gay B; Li-Pat-Yuen G; Hoarau JJ; Jaffar-Bandjee MC; Briant L; Gasque P; Denizot M
    Virol J; 2011 Sep; 8():432. PubMed ID: 21902836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential susceptibility & replication potential of Vero E6, BHK-21, RD, A-549, C6/36 cells &
    Sudeep AB; Vyas PB; Parashar D; Shil P
    Indian J Med Res; 2019 Jun; 149(6):771-777. PubMed ID: 31496530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.
    Tumkosit U; Siripanyaphinyo U; Takeda N; Tsuji M; Maeda Y; Ruchusatsawat K; Shioda T; Mizushima H; Chetanachan P; Wongjaroen P; Matsuura Y; Tatsumi M; Tanaka A
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling.
    Varghese FS; Thaa B; Amrun SN; Simarmata D; Rausalu K; Nyman TA; Merits A; McInerney GM; Ng LFP; Ahola T
    J Virol; 2016 Nov; 90(21):9743-9757. PubMed ID: 27535052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral.
    Delang L; Segura Guerrero N; Tas A; Quérat G; Pastorino B; Froeyen M; Dallmeier K; Jochmans D; Herdewijn P; Bello F; Snijder EJ; de Lamballerie X; Martina B; Neyts J; van Hemert MJ; Leyssen P
    J Antimicrob Chemother; 2014 Oct; 69(10):2770-84. PubMed ID: 24951535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palmitoylated Cysteines in Chikungunya Virus nsP1 Are Critical for Targeting to Cholesterol-Rich Plasma Membrane Microdomains with Functional Consequences for Viral Genome Replication.
    Bakhache W; Neyret A; Bernard E; Merits A; Briant L
    J Virol; 2020 May; 94(10):. PubMed ID: 32132240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FHL1 is a major host factor for chikungunya virus infection.
    Meertens L; Hafirassou ML; Couderc T; Bonnet-Madin L; Kril V; Kümmerer BM; Labeau A; Brugier A; Simon-Loriere E; Burlaud-Gaillard J; Doyen C; Pezzi L; Goupil T; Rafasse S; Vidalain PO; Bertrand-Legout A; Gueneau L; Juntas-Morales R; Ben Yaou R; Bonne G; de Lamballerie X; Benkirane M; Roingeard P; Delaugerre C; Lecuit M; Amara A
    Nature; 2019 Oct; 574(7777):259-263. PubMed ID: 31554973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular and molecular mechanisms of chikungunya pathogenesis.
    Lum FM; Ng LF
    Antiviral Res; 2015 Aug; 120():165-74. PubMed ID: 26092642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of a novel antiviral agent targeting the nonstructural protein 4 (nsP4) of chikungunya virus.
    Wada Y; Orba Y; Sasaki M; Kobayashi S; Carr MJ; Nobori H; Sato A; Hall WW; Sawa H
    Virology; 2017 May; 505():102-112. PubMed ID: 28236746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A polarized cell model for Chikungunya virus infection: entry and egress of virus occurs at the apical domain of polarized cells.
    Lim PJ; Chu JJ
    PLoS Negl Trop Dis; 2014 Feb; 8(2):e2661. PubMed ID: 24587455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Andrographolide Mitigates Unfolded Protein Response Pathway and Apoptosis Involved in Chikungunya Virus Infection.
    Gupta S; Mishra KP; Kumar B; Singh SB; Ganju L
    Comb Chem High Throughput Screen; 2021; 24(6):849-859. PubMed ID: 32819227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chikungunya virus infection results in higher and persistent viral replication in aged rhesus macaques due to defects in anti-viral immunity.
    Messaoudi I; Vomaske J; Totonchy T; Kreklywich CN; Haberthur K; Springgay L; Brien JD; Diamond MS; Defilippis VR; Streblow DN
    PLoS Negl Trop Dis; 2013; 7(7):e2343. PubMed ID: 23936572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suramin Inhibits Chikungunya Virus Replication by Interacting with Virions and Blocking the Early Steps of Infection.
    Albulescu IC; White-Scholten L; Tas A; Hoornweg TE; Ferla S; Kovacikova K; Smit JM; Brancale A; Snijder EJ; van Hemert MJ
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32191995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.